[1]吕学鹏,朱海东,熊非,等.介入栓塞治疗用材料和器材研究进展[J].介入放射学杂志,2025,34(02):200-205.
　LV Xuepeng,ZHU Haidong,XIONG Fei,et al.Advances in materials and devices for interventional embolization therapy[J].journal interventional radiology,2025,34(02):200-205.
点击复制

介入栓塞治疗用材料和器材研究进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
34
期数:
2025年02
页码:
200-205
栏目:
综述
出版日期:
2025-02-17

文章信息/Info

Title:
Advances in materials and devices for interventional embolization therapy
作者:
吕学鹏; 朱海东; 熊非; 滕皋军
Author(s):
LV Xuepeng; ZHU Haidong; XIONG Fei; TENG Gaojun.
State Key Laboratory of Digital Medical Engineering，Jiangsu Provincial Key Laboratory for Biomaterials and Devices，School of Biological Science and Medical Engineering，Southeast University，Nanjing，Jiangsu Province 210009，China
关键词:
【关键词】经导管动脉栓塞; 介入放射学; 栓塞剂; 栓塞器材
文献标志码:
A
摘要:
【摘要】经导管动脉栓塞作为一种微创手术，主要通过选择性血管内阻塞治疗肿瘤及血管性疾病。临床应用的栓塞剂种类繁多，包括固体栓塞剂、液体栓塞剂和栓塞器材。固体栓塞剂，尤其是微球类栓塞剂，因其粒径具有一致性和可控性，能够有效实现对肿瘤血管的精准栓塞。这类栓塞剂不仅能阻断血流，还能携带药物，使得药物在栓塞的同时得以释放，从而提高治疗效果。此外，结合有不透射线成分（如碘、钡和钽等）的栓塞微球，可实现固有可追踪性，能实时监测栓塞剂在体内进程，并向医师提供及时反馈。该文作为第一部分，综述了固体栓塞剂（重点关注栓塞微球）的研究成果，旨在推动这一科研领域的发展。

参考文献/References:

［1］Hu J，Albadawi H，Chong B，et al.Advances in biomaterials and technologies for vascular embolization［J］.Adv Mater，2019，31：1901071.
［2］王书晗，彭俊，黄元礼，等.药物洗脱栓塞微球研究进展［J］.中国药事，2024，38：934-944.
［3］吴迪，郑琳.载药微球栓塞治疗在肝癌全程管理中的临床应用进展［J］.介入放射学杂志，2024，33：921-927.
［4］Kunstlinger F，Brunelle F，Chaumont P，et al.Vascular occlusive agents［J］.AJR Am J Roentgenol，1981，136：151-156.
［5］Dick R.Radiology now.Therapeutic angiographic embolization［J］.Br J Radiol 1977，50：241-242.
［6］Osuga K，Maeda N，Higashihara H，et al.Current status of embolic agents for liver tumor embolization［J］.Int J Clin Oncol，2012，17：306-315.
［7］Negussie AH，Dreher MR，Johnson CG，et al.Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization［J］.J Mater Sci Mater Med，2015，26：198.
［8］Li X，Ji X，Chen K，et al.Immobilized thrombin on X-ray radiopaque polyvinyl alcohol/chitosan embolic microspheres for precise localization and topical blood coagulation［J］.Bioact Mater，2021，6：2105-2119.
［9］Sakr OS，Berndt S，Carpentier G，et al.Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology［J］.J Control Release，2016，224：199-207.
［10］Chen M，Shu G，Lv X，et al.HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma［J］.Biomaterials，2022，284：121512.
［11］de Baere T，Plotkin S，Yu RN，et al.An in vitro evaluation of four types of drug-eluting microspheres loaded with doxorubicin［J］.J Vasc Interv Radiol，2016，27：1425-1431.
［12］Aliberti C，Carandina R，Sarti D，et al.Chemoembolization adopting polyethylene glycol drug-eluting embolics loaded with doxorubicin for the treatment of hepatocellular carcinoma［J］.AJR Am J Roentgenol，2017，209：430-434.
［13］Lucatelli P，Ginnani Corradini L，De Rubeis G，et al.Balloon-Occluded transcatheter arterial chemoembolization （b-TACE） for hepatocellular carcinoma performed with polyethylene-glycol epirubicin-loaded drug-eluting embolics：safety and preliminary results［J］.Cardiovasc Intervent Radiol，2019，42：853-862.
［14］Li J，Xu J，Wang Y，et al.Fusible and radiopaque microspheres for embolization［J］.Adv Mater，2024：e2405224.
［15］李瑞，周军，于炜婷，等.动脉栓塞微球的研究进展［J］.生物医学工程与临床，2023，27：247-252.
［16］杨延杰，马靖嶔，颜志平.可视化微球研究进展［J］.介入放射学杂志，2024，33：115-121.
［17］Ye Y，Ren Y，Zeng H，et al.Characterization of calibrated gelatin sponge particles in a rabbit renal embolization model［J］.Cardiovasc Intervent Radiol，2019，42：1183-1191.
［18］Zhao G，Li C，Liu Y，et al.350～560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma：the safety and efficacy［J］.Medicine （Baltimore），2017，96：e6629.
［19］Rana MM，Melancon MP.Emerging polymer materials in trackable endovascular embolization and cell delivery：from hype to hope［J］.Biomimetics，2022，7：77.
［20］Gao F，Han T，Rafiq M，et al.Two-in-One visual gelatin embolization microspheres for precise localization and rapid embolization studies［J］.ACS Materials Letters，2023，5：1859-1869.
［21］Wang YX，De BT，Idee JM，et al.Transcatheter embolization therapy in liver cancer：an update of clinical evidences［J］.Chin J Cancer Res，2015，27：96-121.
［22］Yi Z，Sun Z，Shen Y，et al.The Sodium hyaluronate microspheres fabricated by solution drying for transcatheter arterial embolization［J］.J Mater Chem B，2022，10：4105-4114.
［23］王文焕.X光显影碘代聚乳酸介入栓塞材料合成与性能［D］.大连：大连理工大学，2019.
［24］陈泽宇，付烨，张茜，等.PLGA的降解行为及应用研究进展［J］.中国塑料，2024，38：92-99.
［25］王晓芳，符乐，张盼盼，等.PLGA纳米粒及其在生物医学领域的应用潜力［J］.中国畜牧兽医，2024，51：33-41.
［26］Choi JW，Park JH，Cho HR，et al.Sorafenib and 2，3，5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor［J］.Sci Rep，2017，7：554.
［27］Jeon SI，Kim MS，Kim HJ，et al.Biodegradable poly（lactide-co-glycolide） microspheres encapsulating hydrophobic contrast agents for transarterial chemoembolization［J］.J Biomater Sci Polym Ed，2022，33：409-425.
［28］Chiang PF，Peng CL，Shih YH，et al.Biodegradable and multifunctional microspheres for treatment of hepatoma through transarterial embolization［J］.ACS Biomater Sci Eng，2018，4：3425-3433.
［29］Xuan F，Rong J，Liang M，et al.Biocompatibility and effectiveness evaluation of a new hemostatic embolization agent：thrombin loaded alginate Calcium microsphere［J］.Biomed Res Int，2017，2017：1875258.
［30］王继华.含钽纳米粒子的海藻酸钙自显影载药微球的实验研究［D］.武汉：华中科技大学，2019.
［31］Chen G，Wei R，Huang X，et al.Synthesis and assessment of Sodium alginate-modified silk fibroin microspheres as potential hepatic arterial embolization agent［J］.Int J Biol Macromol，2020，155：1450-1459.
［32］Choi H，Choi B，Yu B，et al.On-demand degradable embolic microspheres for immediate restoration of blood flow during image-guided embolization procedures［J］.Biomaterials，2021，265：120408.
［33］Liu KL，Jin ZC，Hu XL，et al.A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization［J］.Int J Biol Macromol，2020，142：866-878.
［34］Zheng Z，Ma M，Han X，et al.Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma［J］.Acta Biomater，2023，157：337-351.
［35］Weng L，Rostamzadeh P，Nooryshokry N，et al.In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release［J］.Acta Biomater，2013，9：6823-6833.
［36］Du L，Huang Y，Zhang Q，et al.Synthesis and assessment of drug-eluting microspheres for transcatheter arterial chemoembolization［J］.Acta Biomater，2019，88：370-382.
［37］Leng F，Lei S，Luo B，et al.Size-tunable and biodegradable thrombin-functionalized carboxymethyl chitin microspheres for endovascular embolization［J］.Carbohydr Polym，2022，286：119274.
［38］Liu L，Liang X，Xu A，et al.Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer［J］.Acta Biomater，2021，130：374-384.
［39］肖正芳，郑游冰，邓飞燕，等.基于TACE联合治疗原发性肝细胞癌的研究进展［J］.介入放射学杂志，2024，33：688-692.

相似文献/References:

[1]苏洪英,徐克.介入病房对介入放射学学科发展影响的研究[J].介入放射学杂志,2008,(05):357.
　SU Hongying,XU Ke.Effect of interventional ward to the development of interventional radiology[J].journal interventional radiology,2008,(02):357.
[2]滕皋军,秦永林.重视介入手段在糖尿病足综合治疗中的作用[J].介入放射学杂志,2008,(05):305.
　TENG Gaojun,QIN Yonglin.More attention on the application of interventional management in patients with diabetic foot[J].journal interventional radiology,2008,(02):305.
[3]梁惠民,冯敢生.积极推进泌尿系统疾病介入的临床应用和基础研究[J].介入放射学杂志,2008,(09):609.
　LIANG Huiming,FENG Gansheng.Further promoting the clinical application and fundamental research for interventional radiology of urinary system[J].journal interventional radiology,2008,(02):609.
[4]尹国文,陈世,冯纯伟,等.新“三管法”介入治疗胸内食管胃吻合口瘘[J].介入放射学杂志,2008,(11):812.
　YIN Guowen,CHEN Shixi,FEN Chunwei,et al.The new“３－tube”interventional therapy for gastroesophageal anastomotic fistula[J].journal interventional radiology,2008,(02):812.
[5]丁鹏绪,韩新巍,水少锋,等.布加综合征：搅拌溶栓治疗下腔静脉内新鲜血栓形成[J].介入放射学杂志,2010,(02):127.
　DING Pengxu,HAN Xinwei,SHUI Shaofeng,et al.Agitating thrombolysis technique for the treatment of inferior vena cava fresh thrombus in patients with Budd－Chiari syndrome[J].journal interventional radiology,2010,(02):127.
[6]任重阳,狄镇海,李麟荪.深化医学教学改革，加强介入放射学后备力量培养——医学生调查引起的反思[J].介入放射学杂志,2010,(02):146.
　REN Chongyang,DI Zhenhai,LI Linsun.Deepening the reform of medical education，strengthening the training of reserve specialists in interventional radiology：a profound rethinking based on a survey of medical students[J].journal interventional radiology,2010,(02):146.
[7]韩新巍,汪南,吴刚,等.食管胸腔胃吻合口内支架并发食管气管瘘的内支架再置入治疗[J].介入放射学杂志,2010,(06):496.
　HAN Xinwei,WANG Nan,WU Gang,et al.Re－stenting treatment for esophagotracheal fistula caused by intrathoracic gastroesophageal anastomosis stent[J].journal interventional radiology,2010,(02):496.
[8]徐克,钟红珊.加强介入医师临床思维与能力培养的重要性和紧迫性[J].介入放射学杂志,2010,(08):598.
　XU Ke,ZHONG Hongshan.Importance of training on clinical thinking and clinical competence to interventional radiologists[J].journal interventional radiology,2010,(02):598.
[9]吴刚,司江涛,韩新巍,等.改良型Y型自膨胀式金属内支架治疗五例残胃－空肠吻合口狭窄[J].介入放射学杂志,2010,(08):627.
　WU Gang,SI Jiangtao,HAN Xinwei,et al.Implantation of modified Y－shaped self－expandable stent for the treatment of stenosis of gastroenteric stomapreliminary results in five cases[J].journal interventional radiology,2010,(02):627.
[10]丁鹏绪,吴刚,韩新巍,等.Budd－Chiari综合征：预开通治疗下腔静脉内陈旧性血栓[J].介入放射学杂志,2010,(09):702.
　DING Pengxu,WU Gang,HAN Xinwei,et al.Predilation technique for the treatment of old inferior vena cava thrombus in patients with Budd－Chiari syndrome[J].journal interventional radiology,2010,(02):702.

备注/Memo

备注/Memo:
（收稿日期：2024-05-20）
（本文编辑：谷珂）
更新日期/Last Update: 2025-02-17